Author

Vladimır Majerčiak

National Institutes of HealthORCID 0000-0003-2907-4583Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Maggie C. CamiD· 3 shared Zhi‐Ming ZhengiD· 3 shared Alexei V. LobanoviD· 2 shared Douglas R. LowyiD· 2 shared Lulu YuiD· 2 shared Baktiar O. KarimiD· 1 shared Beatriz Alvarado-HernandeziD· 1 shared Chu‐Xia DengiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Maggie C. CamORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 14, 2025

SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression

Lulu Yu, Masahiko Ajiro, Alexei V. Lobanov…·Zhi‐Ming Zheng

This study shows SRSF3 is oncogenic in breast cancer and tumor-suppressive in liver cancer through context-dependent gene regulation.

1 citation

mouseexperimental assay

𝕏 PostBluesky

MicrobiologymBioPeer-reviewedDec 10, 2024

KSHV promotes oncogenic FOS to inhibit nuclease AEN and transactivate RGS2 for AKT phosphorylation

Vladimır Majerčiak, Beatriz Alvarado-Hernandez, Yanping Ma…·Zhi‐Ming Zheng

This study identifies KSHV ORF57 as a viral RNA-binding protein that stabilizes FOS RNA, inhibits AEN, and transactivates RGS2 to promote AKT phosphorylation during lytic infection.

7 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyeLifePeer-reviewedNov 28, 2024

The lnc-FANCI-2 intrinsically restricts RAS signaling in HPV16-infected cervical cancer

Haibin Liu, Lulu Yu, Vladimır Majerčiak…·Zhi‐Ming Zheng

This study identifies lnc-FANCI-2 as a regulator of RAS signaling in HPV16-infected cervical cancer, showing its role in lesion progression and patient survival.

3 citations

humanproteomics

𝕏 PostBluesky